Transcenta Therapeutics (Hangzhou) Co., Ltd.
Transcenta Therapeutics (Hangzhou) Co., Ltd.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Phase 3 | 2026-09-29 | NCT06093425 | |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colorectal adenocarcinoma, metastatic neoplasm, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT05731271 | |
| A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors | Advanced Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT04495296 | |
| A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, endocrine system disorder, gastric cancer, gastric neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, stomach disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT04396821 | |
| Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis, postmenopausal osteoporosis, sclerosteosis | Not yet recruiting | Phase 2 | 2026-09-11 | NCT07806331 | |
| 68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy | Digestive System Diseases, cancer, digestive system disorder, intestinal disorder, neoplasm, protein-losing enteropathy | Not yet recruiting | Not stated | 2024-12-04 | NCT06716788 |